Hospira Epirubicin Hydrochloride Injection 10 mg/5 mL single dose vial Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

hospira epirubicin hydrochloride injection 10 mg/5 ml single dose vial

hospira australia pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections - 1. relief of subjective and objective symptoms in the following diseases: acute leukaemia, malignant lymphoma, breast cancer, ovarian cancer, stomach cancer, liver cancer, urothelial cancer (bladder cancer, renal pelvic/ureteral cancer) 2. treatment of the following malignant cancer in conjunction with other anti-malignant cancer drugs: breast cancer (pre- and post-operative chemotherapy in operable cases)

Hospira Oxaliplatin Injection 50mg/10mL vial Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

hospira oxaliplatin injection 50mg/10ml vial

hospira australia pty ltd - oxaliplatin, quantity: 5 mg/ml - injection, intravenous infusion - excipient ingredients: tartaric acid; sodium hydroxide; water for injections - oxaliplatin, used in combination with infusional 5-fluorouracil/leucovorin, is indicated for: * adjuvant treatment of stage iii colon cancer in patients who have undergone complete resection of the primary tumor. * treatment of advanced colorectal cancer.

Hospira Oxaliplatin Injection 100 mg/20 mL vial Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

hospira oxaliplatin injection 100 mg/20 ml vial

hospira australia pty ltd - oxaliplatin, quantity: 5 mg/ml - injection, intravenous infusion - excipient ingredients: tartaric acid; sodium hydroxide; water for injections - oxaliplatin, used in combination with infusional 5-fluorouracil/leucovorin is indicated for: * adjuvant treatment of stage iii colon cancer in patients who have undergone complete resection of the primary tumour * treatment of advanced colorectal cancer.

Hospira irinotecan hydrochloride trihydrate IV Infusion 100 mg Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

hospira irinotecan hydrochloride trihydrate iv infusion 100 mg

hospira australia pty ltd - irinotecan hydrochloride trihydrate, quantity: 20 mg/ml - injection, intravenous infusion - excipient ingredients: lactic acid; sorbitol; water for injections - small cell lung carcinoma, non-small cell lung carcinoma, cervical carcinoma, ovarian cancer, stomach cancer (inoperable or recurrent), colorectal cancer (inoperable or recurrent), breast cancer (inoperable or recurrent), squamous cell carcinoma, malignant lymphoma (non hodgkin's disease).

Hospira irinotecan hydrochloride trihydrate IV Infusion 40 mg Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

hospira irinotecan hydrochloride trihydrate iv infusion 40 mg

hospira australia pty ltd - irinotecan hydrochloride trihydrate, quantity: 20 mg/ml - injection, intravenous infusion - excipient ingredients: lactic acid; sorbitol; water for injections - small cell lung carcinoma, non-small cell lung carcinoma, cervical carcinoma, ovarian cancer, stomach cancer (inoperable or recurrent), colorectal cancer (inoperable or recurrent), breast cancer (inoperable or recurrent), squamous cell carcinoma, malignant lymphoma (non hodgkin's disease).

Hospira Gemcitabine for IV Infusion 1 g Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

hospira gemcitabine for iv infusion 1 g

hospira australia pty ltd - gemcitabine hydrochloride, quantity: 45.54 mg/ml - injection, intravenous infusion - excipient ingredients: mannitol; sodium acetate trihydrate - non-small cell lung cancer, pancreatic cancer, biliary tract cancer, uroepithelial cancer, inoperable or recurrent breast cancer, ovarian cancer progressing after chemotherapy.

Hospira Gemcitabine for IV Infusion 200 mg Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

hospira gemcitabine for iv infusion 200 mg

hospira australia pty ltd - gemcitabine hydrochloride, quantity: 45.54 mg/ml - injection, intravenous infusion - excipient ingredients: mannitol; sodium acetate trihydrate - non-small cell lung cancer, pancreatic cancer, biliary tract cancer, uroepithelial cancer, inoperable or recurrent breast cancer, ovarian cancer progressing after chemotherapy.

Hospira Tomudex powder for solution for infusion 2 mg/vial Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

hospira tomudex powder for solution for infusion 2 mg/vial

hospira australia pty ltd - raltitrexed, quantity: 2 mg - injection, powder for - excipient ingredients: mannitol; dibasic sodium phosphate dodecahydrate - pallative treatment of advanced colorectal cancer where 5-flourouracil and folinic acid based regimens are either not tolerated or inappropriate.

Hospira Gemcitabine Injection (38 mg/mL) 200 mg/5.26 mL (US) Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

hospira gemcitabine injection (38 mg/ml) 200 mg/5.26 ml (us)

hospira australia pty ltd - gemcitabine hydrochloride, quantity: 43.27 mg/ml; water for injections - injection, solution - excipient ingredients: sodium hydroxide; hydrochloric acid - ovarian cancer, breast cancer, non small cell lung cancer, pancreatic cancer

Hospira Gemcitabine Injection (38 mg/mL) 1 g/26.3 mL (US) Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

hospira gemcitabine injection (38 mg/ml) 1 g/26.3 ml (us)

hospira australia pty ltd - gemcitabine hydrochloride, quantity: 43.27 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; hydrochloric acid; water for injections - ovarian cancer, breast cancer, non small cell lung cancer, pancreatic cancer